AzTrials
AzTrials

CompetenceNCT05612113

Live Supervision in Psychotherapy: Study Protocol for a Single Case Experimental Design Study (SCED)

A study testing Live Supervision + Session Goal Formulation and Session Goal Formulation in people with Competence, run by Karolinska Institutet at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Although clinical supervision is an essential part of psychotherapy training and development, the empirical evidence for effects on therapist competence and patient outcome is limited. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Competence
What is being tested?
Live Supervision + Session Goal Formulation and Session Goal Formulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteSweden
Study dates
1 Oct 2022to Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • At least one diagnosis of the following DSM-5 disorders: mood disorders, anxiety disorders, OCD or related disorders, orTrauma or stress related disorders, comorbid severe disorder such as schizophrenia or development disorder,
  • Being able to attend to regular treatment
  • Accepting recording of therapy sessions and providing a written consent
  • Above 16 years old
  • Licensed psychologist
  • Working in outpatient psychiatric care or primary care in Sweden
Show all 11Show fewer
  • Currently providing CBT
  • At least one year work experience of providing psychological treatments in outpatient care
  • Supervisors:
  • At least 2 years experience working as a clinical supervisor for CBT
  • Formal supervision training

Who cannot join

  • Comorbid severe disorder such as schizophrenia, developmental disorder, severe eating disorder, or severe substance use disorder.
  • Therapists:

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska Institute

    Stockholm, Region Stockholm, 17177

Other trials in Sweden

About this study

Official title: Live Supervision in Psychotherapy: Study Protocol for a Single Case Experimental Design Study (SCED) With Multiple Baselines in an Outpatient Clinical Setting

Although clinical supervision is an essential part of psychotherapy training and development, the empirical evidence for effects on therapist competence and patient outcome is limited. However, a novel format, Live Supervision (LS), enables real time feedback during the patient session which counteracts on several of the major identified problems with standard supervision. Pilot studies of LS show promising results, but the effects of LS has never been assessed in a clinical setting with licensed psychologists. Furthermore, manualized LS with a stringent focus at therapists' idiosyncratic challenges has never been evaluated.

The primary aim of this study is to evaluate the effects of LS on therapist competence and perceived therapy challenges in a clinical outpatient setting with licensed psychologists as therapists. Secondary aims are to examine when and how LS is optimal for clinical supervision.

Read the detailed description

Objective:

To evaluate the effects of LS on therapist competence and perceived therapy challenges with both qualitative and quantitative data in a sample of licensed psychotherapists working with CBT in outpatient psychiatry or primary care.

Methods:

The study will use a replicated Single Case Experimental Design (SCED) with randomized multiple baselines in combination with qualitative interviews at the end of the trial. Each therapist (n = 6) will take part in the study with one patient for a period of 14 therapy sessions of which 5-9 sessions (randomized for each therapist) consist of the baseline phase, followed by the intervention phase (Live Supervision) for the rest of the study period (5-9 sessions).

Primary outcome measures will be observer rated competence and observer and therapist rated goal attainment. Secondary outcome measure will be the quality of therapy sessions from the perspective of the patients and observer rated competence according to the supervisors perception of the most prevalent skill deficiency of the therapist.

The qualitative data collection will focus on a systemization of how and when LS is for optimal use as well as mapping the degree of correspondence between patients, therapists, and supervisors regarding the therapists competences and skill deficiencies.

Conditions
Competence
Being tested
Live Supervision + Session Goal Formulation, Session Goal Formulation
Keywords
Clinical Supervision, Therapist Competence, Training and Supervision, Live Supervision, Psychotherapy, Bug-in-the-Ear

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Live Supervision + Session Goal FormulationBehavioural

    Read under "Arms"

  • Session Goal FormulationOther

    Read under "Arms"

Study groups in NCT05612113
Study groupRoleWhat they receive
Baseline - Session Goal FormulationActive comparatorIn the baseline phase, the therapist will formulate two session goals, see under descriptions of primary outcome measure. In this SCED-study, the baseline phase will be of randomized length (5-9 sessions) for each therapist. The reason for defining this as an active comparator is that we the behavior of formulating two session goals before each session should be considered an intervention, stimulating the therapist to reflect on the upcoming session goals, on defining concrete behaviors to reach the session goal, and to reflect upon his/her session behaviors afterwards. Thus, regarding the baselinephase as a no intervention would be misleading.
Receives: Other: Session Goal Formulation
Live Supervision with Bug-in-the-Ear (BITEar) as methodExperimentalLS with the Bug-in-the-Ear (BITEar) is a video based supervision format where the supervisor watches the therapy session live through a webcam in the therapy room. During the therapy session, the supervisor provide verbal feedback and guidance to the therapist who wears wireless in-ear headphones. In this SCED-study, the intervention phase consist of 5 to 9 BITEar supervision sessions (number of supervision sessions is randomized between therapists) The BITEar supervision will consist of three phases: Pre-supervision (15 minutes): Discussion of the therapists session goals, how the therapist wants the supervisor's help and agreement on prompts and cues from supervisor Live supervision during the therapy session (≈ 45-60 minutes): Supervisor gives real time feedback and guidance focusing on helping the therapist achieve session goals Post-supervision (15 minutes): Reflection about the session, session goals and the supervision.
Receives: Behavioral: Live Supervision + Session Goal Formulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Therapist Rated Session Goal Attainment of Idiosyncratically Formulated Session Goals

    All therapists will formulate two individual development goals per therapy session for the 14 weeks. One goal is focusing on a challenging behavioral pattern of the patient (e.g. talkative), and the other focusing on a challenging behavior of the therapist (e.g. being concise).

    After each session, each therapist rates to what degree they perceived that they managed to reach each of their set up goals on a scale from 0 (not reached the goal at all) to 100 (fully reached the goal) with 5 anchor points with descriptions. They will also rate the perceived difficulty of working with the goal from a scale from 0 (not at all difficult) to 100 (extremely difficult) with 5 anchor points with descriptions.

    Measured: Approximately 14 weeks (from session 1 to session 14 with one session per week)

  2. Observer Rated Session Goal Attainment of Idiosyncratically Formulated Session Goals

    Third-party raters will listen to the audio recordings of the sessions and evaluate the level of goal attainment in each session, blinded to whether the therapist received supervision or not. Observers will be trained in how to evaluate goal attainment.

    Measured: Approximately 14 weeks (from session 1 to session 14 with one session per week)

  3. Therapist Competence measured with Cognitive Therapy Scale - Revised (CTS-R; Blackburn et al., 2001)

    The CTS-R instrument is one of the most used and validated scales for measuring CBT competence. The scale consists of 12 items with a 7-point rating scale format: 0 = poor, 1 = barely adequate, 2 = mediocre, 3 = satisfactory, 4 = good, 5 = very good, and 6 = excellent.

    In this study, we will analyze both the composite score of the full scale, but also an item per item analysis since one of the aims of the study is to assess for what type of competencies LS may be particularly effective.

    Measured: Approximately 14 weeks (from session 1 to session 14 with one session per week)

Secondary outcomes (4)
  1. Patient rated degree of satisfaction and usefulness

    Each session, the patient will rate how satisfied and how useful they perceived the session. The rating is on a scale from 0 (not at all) to 100 (extremely)

    Measured: Approximately 14 weeks (from session 1 to session 14 with one session per week)

  2. Patient rated degree of collaboration with the therapist

    As a proxy measure for therapeutic alliance, a single item will be used where the patient is asked to rate how they perceived the collaboration with their therapist on a scale from 0 (not good at all) to 100 (extremely good).

    Measured: Approximately 14 weeks (from session 1 to session 14 with one session per week)

  3. Observer rated degree of therapist skill deficiency as defined by the supervisor

    During the interviews in the end of the trial, the supervisors will be asked to define the most important therapist skill deficiency. This skill will then be operationalized and rated for each session by a blinded third party rater.

    Measured: Approximately 14 weeks (from session 1 to session 14 with one session per week)

  4. Observer rated degree of therapist skill deficiency as defined by the patient

    During the interviews in the end of the trial, the patients will be asked to define the most important therapist skill deficiency. This skill will then be operationalized and rated for each session by a blinded third party rater.

    Measured: Approximately 14 weeks (from session 1 to session 14 with one session per week)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2022
  2. Study start1 Oct 2022
  3. Primary completionMar 2023 (estimated)
  4. Study completionMar 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Sequential
Model description
Replicated Single Case Experimental Design with Multiple Baselines
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05612113
Sponsor's protocol ID
2022-00352-01
Status last verified
Nov 2022
First submitted
17 Oct 2022
Last updated
10 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Live Supervision + Session Goal Formulation and Session Goal Formulation in people with Competence, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Therapist Rated Session Goal Attainment of Idiosyncratically Formulated Session Goals (time frame: Approximately 14 weeks (from session 1 to session 14 with one session per week)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Nov 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in